Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial
Kim A. Margolin, P. Y. Liu, Joseph M. Unger, William S. Fletcher, Lawrence E. Flaherty, Walter J. Urba, Evan M. Hersh, Laura E. Hutchins, Jeffrey A. Sosman, John W. Smith, Geoffrey R. Weiss, Vernon K. Sondak
Dive into the research topics of 'Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial'. Together they form a unique fingerprint.